The invention relates to new therapeutic approaches for treating cancer in particular hepatocellular carcinoma with Nanoparticules loaded with a chemotherapeutic antitumoral agent. In particular it relates to the treatment of cancer by administration of said Nanoparticules by intravenous infusion for at least 2 hours in order to prevent toxicological side effects and increase the benefit/risk ratio of the treatment.
